Global Embolization Agent Market To Register A CAGR Of 9.7% Over 2018-2022

Date: 2018-05-07

Embolization or embolisation refers to the passage and lodging of an embolus within the bloodstream. Embolic agents are administered as part of an overall therapeutic approach to tumors and vascular pathology of the central nervous system. The choice of embolic agent depends on the clinical goal of the embolization procedure, i.e., permanent or temporary occlusion, taking into account the target vascular anatomy.

The growing population in developing countries, and rising aging population, according to the UICC (Union for International Cancer Control), over the next two decades, globally cancer cases will increase by nearly 75%, reaching almost to 25 million, there are the major factors to drive the growth for the Global Embolization Agent market, the Global Embolization Agent market is expected to grow at a CAGR of 9.7% over 2018-2022..

In terms of geography, the North America is dominating the market which is the largest Embolization Agent technologies market in the year 2017, region followed by Europe. 

However, since the Asia Pacific is experiencing the growing population and increasing geriatric population, which results in estimating to exhibit the fastest growth rate owing to the expected rise in various types of cancer coupled with high research and development initiatives and growing adoption rate for advanced therapeutic Embolization Agent.

Base on application, among the various applications of Embolization Agent, liver cancer, brain cancer, lung cancer and breast cancer and prostate cancer, liver cancer is expected to witness the fastest growth during the forecast period owing to the high incidence and prevalence rate of these cancers and high adoption rate for Embolization Agent for therapeutic treatment.

Global top manufacturers operating in Embolization Agent Market are Astellas Pharma, Nippon Kayaku, Pfizer, Boston, Cook Medical among others.

Global Embolization Agent market share by region as following:

Read Full Report:

Joanna | Executive – International Business and partner Relations
E-mail: | Tel: 510-400-8520


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample